EVAX
Price
$1.54
Change
+$0.05 (+3.36%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
10.04M
WXIBF
Price
$2.74
Change
+$0.32 (+13.22%)
Updated
Apr 14 closing price
Capitalization
11.93B
Ad is loading...

EVAX vs WXIBF

Header iconEVAX vs WXIBF Comparison
Open Charts EVAX vs WXIBFBanner chart's image
Evaxion Biotech A/S
Price$1.54
Change+$0.05 (+3.36%)
Volume$500
Capitalization10.04M
Wuxi Biologics Cayman
Price$2.74
Change+$0.32 (+13.22%)
Volume$5.4K
Capitalization11.93B
EVAX vs WXIBF Comparison Chart
Loading...
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVAX vs. WXIBF commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a StrongBuy and WXIBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (EVAX: $1.59 vs. WXIBF: $2.74)
Brand notoriety: EVAX and WXIBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 89% vs. WXIBF: 195%
Market capitalization -- EVAX: $10.04M vs. WXIBF: $11.93B
EVAX [@Biotechnology] is valued at $10.04M. WXIBF’s [@Biotechnology] market capitalization is $11.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whileWXIBF’s FA Score has 2 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • WXIBF’s FA Score: 2 green, 3 red.
According to our system of comparison, WXIBF is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 6 TA indicator(s) are bullish.

  • EVAX’s TA Score: 6 bullish, 2 bearish.

Price Growth

EVAX (@Biotechnology) experienced а +21.47% price change this week, while WXIBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

EVAX is expected to report earnings on Apr 01, 2025.

WXIBF is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXIBF($11.9B) has a higher market cap than EVAX($10M). WXIBF YTD gains are higher at: 26.267 vs. EVAX (-64.750). WXIBF has higher annual earnings (EBITDA): 5.5B vs. EVAX (-9.38M). WXIBF has higher revenues than EVAX: WXIBF (17B) vs EVAX (3.3M).
EVAXWXIBFEVAX / WXIBF
Capitalization10M11.9B0%
EBITDA-9.38M5.5B-0%
Gain YTD-64.75026.267-247%
P/E RatioN/A25.69-
Revenue3.3M17B0%
Total CashN/AN/A-
Total Debt10.5MN/A-
FUNDAMENTALS RATINGS
WXIBF: Fundamental Ratings
WXIBF
OUTLOOK RATING
1..100
99
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
16
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVAX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WULF2.790.14
+5.09%
TeraWulf
PESI8.320.07
+0.91%
Perma-Fix Environmental Services
CNH11.300.02
+0.18%
CNH Industrial NV
PAM77.320.02
+0.03%
Pampa Energia SA
ADXN7.60-0.04
-0.46%
Addex Therapeutics Ltd

EVAX and

Correlation & Price change

A.I.dvisor tells us that EVAX and KURA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVAX and KURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+8.76%
KURA - EVAX
31%
Poorly correlated
+0.95%
LPTX - EVAX
30%
Poorly correlated
N/A
CRGX - EVAX
28%
Poorly correlated
-1.09%
SPRB - EVAX
27%
Poorly correlated
+2.39%
REPL - EVAX
26%
Poorly correlated
+1.38%
More

WXIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXIBF has been loosely correlated with WXXWY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXIBF jumps, then WXXWY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXIBF
1D Price
Change %
WXIBF100%
N/A
WXXWY - WXIBF
46%
Loosely correlated
+2.03%
JAGX - WXIBF
22%
Poorly correlated
+20.84%
NVAX - WXIBF
21%
Poorly correlated
-5.35%
ELVAF - WXIBF
21%
Poorly correlated
N/A
EVAX - WXIBF
20%
Poorly correlated
+6.71%
More